2nd American Company Announces COVID Vaccine, 95 Percent Effective

Modern Inc has announced that its experimental coronavirus vaccine is nearly 95 percent effective.

The announcement makes the company the second in a week to announce a potential vaccine.

“Together with Pfizer Inc’s vaccine, also shown to be more than 90% effective, and pending more safety data and regulatory review, the United States could have two vaccines authorized for emergency use in December with as many as 60 million doses of vaccine available by the year’s end,” Fox Business reports.

Health and Human Services Secretary Alex Azar shared the announcement on “Good Morning America” where he said the Trump administration is expected to have 20 million doses available to give to the “most vulnerable citizens” by the end of the year.

Fox Business reports the initial 20 million doses will quickly be surpassed by more than a billion doses that will be available next year. This would be more than enough to administer to each of the 330 million people living in the United States.

The report adds:

The vaccines, both built using new technology known as messenger RNA or mRNA, represent powerful new tools to fight a pandemic that has infected 54 million people worldwide and killed 1.3 million. The news also comes at time when COVID-19 cases are soaring, hitting new records in the United States and pushing some European countries back into lockdowns.

“We are going to have a vaccine that can stop COVID-19,” Moderna President Stephen Hoge said in a telephone interview.

Moderna’s interim analysis was based on 95 infections among trial participants who received either a placebo or the vaccine. Of those, only five infections occurred in those who received the vaccine, which is administered in two shots 28 days apart.

— Advertisement —

During an interview with MSNBC, leading infectious disease expert Dr. Anthony Fauci similarly said the vaccines “are effective” and will be available to the majority of Americans “into January, February, and March.”

“The vaccines are effective … We want to get doses to people starting in December, and then we want to really get the ball rolling as we get into January, February and March.